Cookson Peirce & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-40,449
Closed -$868K – 327
2026
Q2
$868K Buy
+40,449
New +$620K 0.03% 217
2026
Q1
– Sell
-105,689
Closed -$1.72M – 304
2025
Q4
$1.72M Buy
+105,689
New +$1.72M 0.07% 122
2025
Q3
– Sell
-45,000
Closed -$524K – 307
2025
Q2
$524K Buy
+45,000
New +$409K 0.02% 225

Other funds holding ADPT

Cookson Peirce & Co's ADPT Position: Q3 2026 in Review

Cookson Peirce & Co sold out of Adaptive Biotechnologies (ADPT) in Q3 2026, closing a stake of 40,449 shares — an estimated $868K sold.

Cookson Peirce & Co first reported a position in ADPT in Q2 2025 and held it in 3 quarters. The position peaked at $1.72M in Q4 2025. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Cookson Peirce & Co reported no remaining Adaptive Biotechnologies position as of Q3 2026 after selling out during the quarter.
  • Cookson Peirce & Co sold 40,449 Adaptive Biotechnologies shares in Q3 2026, an estimated $868K.
  • Cookson Peirce & Co first reported a position in Adaptive Biotechnologies in Q2 2025 and held it in 3 quarters.
  • Cookson Peirce & Co's Adaptive Biotechnologies position peaked at $1.72M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.